Once-a-day stimulant is safe for ADHD, can be used after 1 year

Published Date: 13 Mar 2023

New research shows that once-daily speech-stimulating medications for the treatment of ADHD in people age 6 and older are safe and effective after one year of pain treatment.

Read Full News

Latest News

What Drives 50-Day Neurology Wait Times? Not Just Supply

The average wait time for a first neurology appointment is nearly 50 days for commercially insured patients. The cause may not be what you think.

An Effective Alternative to ECT for Major Depression?

A newer brain stimulation therapy matched ECT for depression while causing less memory loss, offering a potential option for patients concerned about cognitive side effects.

Ibogaine: Federal Policy Push Meets Safety Concerns

Ibogaine is getting an accelerated federal research push, but the drug is unapproved and understudied and carries a documented risk for fatal cardiac arrhythmias.

Do Repetitive Motor Behaviors Always Signal Autism?

Repetitive motor behaviors such as hand flapping and rocking occur in more than one third of toddlers who do not meet diagnostic criteria for autism spectrum disorder.

Self-Administered Med Shows Promise in Myasthenia Gravis

Weekly subcutaneous gefurulimab delivered early is linked to lasting symptom improvement in patients with generalized myasthenia gravis in phase 3 PREVAIL trial.

Novel PD Drug May Delay Levodopa Initiation

Tavapadon may delay levodopa use in early Parkinson’s and help stabilize dosing in the later stages of the disease, with most patients avoiding initiation or dose increases.

Todays Updates

Baveno Criteria May Reduce Endoscopy Burden in Cirrhosis

The Baveno VI criteria show high sensitivity for ruling out clinically significant portal hypertension and high-risk varices in patients with cirrhosis.

Todays Updates

Baveno Criteria May Reduce Endoscopy Burden in Cirrhosis

The Baveno VI criteria show high sensitivity for ruling out clinically significant portal hypertension and high-risk varices in patients with cirrhosis.

Latest News

The average wait time for a first neurology appointment is nearly 50 days for commercially insured patients. The cause may not be what you think.

A newer brain stimulation therapy matched ECT for depression while causing less memory loss, offering a potential option for patients concerned about cognitive side effects.

Ibogaine is getting an accelerated federal research push, but the drug is unapproved and understudied and carries a documented risk for fatal cardiac arrhythmias.

Repetitive motor behaviors such as hand flapping and rocking occur in more than one third of toddlers who do not meet diagnostic criteria for autism spectrum disorder.

Weekly subcutaneous gefurulimab delivered early is linked to lasting symptom improvement in patients with generalized myasthenia gravis in phase 3 PREVAIL trial.

Tavapadon may delay levodopa use in early Parkinson’s and help stabilize dosing in the later stages of the disease, with most patients avoiding initiation or dose increases.

News All Time

FDA Seeks New Warning for Certain Parkinson's Drugs

The FDA said on Friday it has notified manufacturers of certain Parkinson's ⁠disease treatments to update their prescribing information with a...

Scottish Lawmakers Vote Against Allowing Assisted Dying

Scottish lawmakers have voted against legalising assisted, crushing hopes for a historic law change, ⁠as similar proposals in England and Wales also look set to fail.

Little Evidence of Cannabis Efficacy for Psychiatric Illness

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

Prenatal Antiseizure Med Exposure: Risks Vary by Agent

A large cohort study sheds new light on neurodevelopmental risk in children after prenatal antiseizure medication exposure, with variation across individual agents.

Anxiety and Depression May Raise Risk for Aneurysm Rupture

Anxiety and depression are linked to an increased risk for rupture and mortality in patients with unruptured intracranial aneurysms, a new cohort study shows.

China Approves Market Launch Of Brain-computer Interface Medical Device in World First

China's drug regulator said on Friday that it has given the nod for a brain-computer interface (BCI) system ⁠that helps restore hand-movement ability to be sold, the world's...

Why Aren’t Canadians Getting Enough Sleep?

The change to daylight saving time and the marking of World Sleep Day call attention to the factors that contribute to sleep deficits among Canadians.

Single IV Ketamine Promising for Depression in MCI

Ketamine is well-tolerated in older adults with both mild cognitive impairment and depression and associated with improved depression scores, a new study shows.

Late Complications Common After CVT, Even After Recovery

Although a majority of patients with cerebral venous sinus thrombosis achieve independence, 1 in 3 may develop delayed complications such as seizures, a study shows.

Activity Trackers May Predict MS Progression

Reduced daytime physical activity, as measured with wearable trackers, is tied to increased risk for multiple sclerosis progression and brain atrophy, new research shows.

WHO Warns Of Health Risks From 'Black Rain' in Iran

The World Health Organization warned on Tuesday that the 'black rain' and toxic compounds in the air in Iran after strikes on ⁠oil facilities could cause respiratory problems.

Wildfire Smoke Tied to Higher Stroke Risk, Greater Severity

Short-term surges in air pollution from wildfire smoke have been linked to a greater incidence and severity of stroke.

Therapeutic Research in Alzheimer’s Disease: What Is New?

Long-term extension trial results with donanemab suggest a widening separation in cognitive decline through 36 months in early Alzheimer’s disease.

Reframing Dyslexia: Ancient Genes, Modern Skill

Study argues to move beyond ‘reading genes’ — focus on conserved neural-development networks in humans to improve early screening and identify therapeutic leads.

Adults With IDDs Face ‘Mental Health Crisis’

Adults with IDDs face disproportionately higher rates of anxiety and depression and barriers to care, prompting researchers to characterize the situation as a ‘mental health crisis.’

Smoking + Parkinson's: Lower Disease Risk, Higher Mortality

A large nationwide study revisits the smoking-Parkinson's paradox, linking current smoking to lower disease risk but linking quitting to lower all-cause mortality.